| Literature DB >> 31694290 |
Anna Parra-Llorca1, María Gormaz1,2, Sheila Lorente-Pozo1, Maria Cernada1,2, Ana García-Robles1, Isabel Torres-Cuevas1, Julia Kuligoswki1, Maria Carmen Collado3, Eva Serna4, Máximo Vento1,2.
Abstract
BACKGROUND: Own mother's milk (OMM) is the optimal nutrition for preterm infants. However, pasteurized donor human milk (DHM) is a valid alternative. We explored the differences of the transcriptome in exfoliated epithelial intestinal cells (EEIC) of preterm infants receiving full feed with OMM or DHM.Entities:
Keywords: donor milk; genetics; inflammation; intestinal cells; mother’s milk; oxidative stress; prematurity
Mesh:
Substances:
Year: 2019 PMID: 31694290 PMCID: PMC6893464 DOI: 10.3390/nu11112677
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Demographic, perinatal, clinical, and analytical data of preterm infants < 32 weeks’ gestation receiving own mother’s milk (OMM) or pasteurized donor human milk (DHM).
| OMM | DHM | ||
|---|---|---|---|
| GA weeks, (median; 5–95% CI) | 29 (28–30) | 30 (29–31) | 0.07 |
| Antenatal Steroids full course, n (%) | 25 (92.6) | 20 (100) | 0.21 |
| Sex male, n (%) | 21 (77.7) | 11 (55) | 0.1 |
| Type of delivery, n (%) | |||
| - Vaginal | 13 (48.1) | 10 (50) | 0.9 |
| - C- Section | 14 (51.8) | 10 (50) | |
| Birth weight (g), mean (SD) | 1206 (264) | 1315 (193) | 0.22 |
| Apgar 1 min (median; 5–95% CI) | 7 (6–9) | 7 (6–9) | 0.48 |
| Apgar 5 min (median; 5–95% CI) | 9 (8–19) | 9 (8–9) | 0.28 |
| Age (d) at sample collection, | 9 (7–11) | 8 (6–10) | 0.52 |
| Chorioamnionitis, n (%) | 4 (14.8) | 2 (10) | 0.62 |
| Persistent ductus arteriosus, n (%) | 8 (29.6) | 6 (30) | 0.98 |
| Antibiotic therapy, n (%) | 11 (40.7) | 6 (30) | 0.45 |
| Bronchopulmonary Dysplasia, n (%) | 1 (3.7) | 0 (0) | 0.38 |
| Intraventricular hemorrhage, n (%) | 6 (22.2) | 3 (15) | 0.53 |
| Necrotizing enterocolitis, n (%) | 1 (3.7) | 0 (0) | 0.38 |
| Retinopathy of prematurity, n (%) | 1 (3.7) | 0 (0) | 0.38 |
Figure 1Flowchart of patients’ recruitment. A total of 47 preterm infants <32 weeks’ gestation or <1500 g were recruited. Out of these, 27 were fed with their own mother’s milk (OMM) and 20 with pasteurized donated human milk (DHM).
Figure 2Principle components analysis (PCA) displays clear spatial separation of variations in expression values in the two groups of samples identified by unsupervised hierarchical clustering. In the 3-dimensional plot, the three principal components PC#1, #2 and #3 of all samples with over 20,000 well-annotated genes and their respective variations are expressed on the x-, y- and z-axis. The total percentage of PCA mapping variability is 12.1%. Each data point represents one sample. The ellipsoids highlight the portioning of the different samples. Assignment of samples by color: OMM (blue) and DHM (green).
Figure 3Heatmap of 27 preterm infants fed their own mother’s milk (OMM; blue bar) and 20 preterm infants fed donated human milk (DHM; green bar) and 1629 genes derived from ANOVA. Each line represents a patient and each column a gene. Overexpressed genes are represented in red and underexpressed genes in blue.
The candidate genes with the highest fold-change between preterm infants < 32 weeks’ gestation/<1.500 g fed their own mother’s milk versus donated human milk in the neonatal period.
| Gene Symbol | Gene Name | Fold-Change | |
|---|---|---|---|
|
| Lactalbumin alpha | 2.9 | 0.002 |
|
| Casein kappa | 2.6 | 0.002 |
|
| Casein beta | 2.1 | 0.009 |
|
| Cytochrome C oxidase subunit1 | 2.1 | 0.030 |
|
| Casein alpha-s1 | 1.7 | 0.008 |
|
| Neutrophil cytosolic factor 1 | −1.6 | 0.040 |
Figure 4Model describing changes in gene expression profile observed in exfoliated epithelial intestinal cells (EEIC). Up-regulated (in red) and down-regulated (in blue) genes in preterm infants fed OMM vs. DHM. The solid line means expression and dashed line means regulation. Relations are colored by effect: Red expresses a negative effect, and green represents a positive effect. Grey means we can observe the unknown effect.
Figure 5Real-time RT-PCR from RNA total of fecal samples from OMM and DHM to validate the biomarker genes COX1 and NCF1.